In the news · 48h FDA 38 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AstraZeneca 3 AbbVie 2 Daiichi Sankyo 2

Trials & R&D · first seen 13h ago, updated 13h ago

Merck’s diabetic macular edema therapy succeeds in Phase 2b/3 trial

1 outlet Merck & Co. (MSD)

Coverage 1 article · 1 outlet

Seeking Alpha Healthcare 13h ago
Merck’s diabetic macular edema therapy succeeds in Phase 2b/3 trial